Entity Details
Details
PrimaryID | 84334 |
RefseqGene | NG_041786 |
Symbol | COA8 |
Name | cytochrome c oxidase assembly factor 8 |
Chromosome | 14 |
Location | 14q32.33 |
TaxID | 9606 |
Status | live |
SourceGenome | genomic |
SourceOrigin | natural |
CreationDate | 2001-05-17 |
ModificationDate | 2021-06-19 |
GO terms
Show/Hide Table
GO | Name |
GO:0000302 | response to reactive oxygen species |
GO:0005739 | mitochondrion |
GO:0033617 | mitochondrial cytochrome c oxidase assembly |
GO:0050821 | protein stabilization |
GO:0097193 | intrinsic apoptotic signaling pathway |
GO:0099617 | matrix side of mitochondrial inner membrane |
GO:1903427 | negative regulation of reactive oxygen species biosynthetic process |
GO:1904960 | positive regulation of cytochrome-c oxidase activity |
Diseases
Show/Hide Table
Disease ID | Source | Name | Description |
619061 | OMIM | Mitochondrial complex IV deficiency, nuclear type 17 (MC4DN17) | An autosomal recessive mitochondrial disorder with highly variable clinical manifestations and severity. Clinical features vary from acute neurometabolic decompensation in late infancy to subtle neurological signs presenting in adolescence. Encephalopathic episodes are characterized by acute loss of developmental milestones including ability to walk or sit, loss of speech, episodes with somnolence and seizure, and pyramidal signs rapidly evolving into spastic tetraparesis. The clinical course subsequently tends to stabilize and in several subjects marked recovery of neurological milestones is observed over time. Brain imaging shows a cavitating leukodystrophy, predominantly involving the posterior cerebral white matter and the corpus callosum in the acute stage, after which the abnormalities partially improve and then stabilize. Patient tissues show variably decreased levels and activity of mitochondrial respiratory complex IV. The disease is caused by variants affecting the gene represented in this entry. |
Interactions
4 interactions